Injecting too shallowly may result in incomplete absorption or faster clearance, reducing the drug's 7-day effect window
These may include nausea, diarrhea, vomiting, acid reflux, and constipation
At week 52, Zepbound resulted in a significant reduction in the apnea-hypopnea index in individuals who were and were not receiving PAP therapy
Comparing popular weight loss drugs Heres a quick rundown of weight loss injections available in the U.S., along with details about their approved use, dosing information, and brand and generic names
Ultimately, some people will develop Type 2 (adult onset) diabetes
In a phase 2 trial, people with T2D and overweight/obesity achieved greater mean WL with cagrisema 2.4 mg compared to cagrilintide 2.4 mg or semaglutide 2.4 mg alone after 32 weeks of treatment (15.6% WL vs